ibuprofen has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 7 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
| Excerpt | Relevance | Reference |
|---|---|---|
| "Standard methods were used to confirm Parkinsonism/neuroprotection." | 1.48 | Ibuprofen Protects from Cypermethrin-Induced Changes in the Striatal Dendritic Length and Spine Density. ( Bala, L; Patel, DK; Singh, A; Singh, MP; Tripathi, P, 2018) |
| "Treatment with ibuprofen or piroxicam in combination with l-dopa preserved the effect of l-dopa at the end of week 10, delayed the development of dyskinesia and decreased striatal COX-2 and VEGF levels." | 1.43 | Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis. ( Moustafa, YM; Teema, AM; Zaitone, SA, 2016) |
| "Post treatment with ibuprofen blocked the depletion of glutathione induced by rotenone and increased the basal levels of this antioxidant in the striatum." | 1.40 | Antidepressant and antioxidative effect of Ibuprofen in the rotenone model of Parkinson's disease. ( Baggio, CH; Barbiero, JK; Bassani, TB; Gradowski, RW; Maria-Ferreira, D; Santiago, RM; Vital, MA; Zaminelli, T, 2014) |
| "Ibuprofen was shown to protect neurons against MPTP-induced injury in the striatum." | 1.39 | Potential neuroprotective effect of ibuprofen, insights from the mice model of Parkinson's disease. ( Członkowski, A; Joniec, I; Kurkowska-Jastrzębska, I; Swiątkiewicz, M; Zaremba, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, A | 2 |
| Tripathi, P | 2 |
| Singh, S | 1 |
| Bala, L | 1 |
| Patel, DK | 1 |
| Singh, MP | 1 |
| Corwin, C | 1 |
| Nikolopoulou, A | 1 |
| Pan, AL | 1 |
| Nunez-Santos, M | 1 |
| Vallabhajosula, S | 1 |
| Serrano, P | 1 |
| Babich, J | 1 |
| Figueiredo-Pereira, ME | 1 |
| Swiątkiewicz, M | 1 |
| Zaremba, M | 1 |
| Joniec, I | 1 |
| Członkowski, A | 2 |
| Kurkowska-Jastrzębska, I | 2 |
| Zaminelli, T | 1 |
| Gradowski, RW | 1 |
| Bassani, TB | 1 |
| Barbiero, JK | 1 |
| Santiago, RM | 1 |
| Maria-Ferreira, D | 1 |
| Baggio, CH | 1 |
| Vital, MA | 1 |
| Teema, AM | 1 |
| Zaitone, SA | 1 |
| Moustafa, YM | 1 |
| Członkowska, A | 1 |
1 review available for ibuprofen and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Neuroinflammatory responses in Parkinson's disease: relevance of Ibuprofen in therapeutics.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Humans; Ibuprofen; Inflammation; Neu | 2021 |
6 other studies available for ibuprofen and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Ibuprofen Protects from Cypermethrin-Induced Changes in the Striatal Dendritic Length and Spine Density.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Corpus Striatum; Dendrites; Dend | 2018 |
Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Disease Models, Animal; Enc | 2018 |
Potential neuroprotective effect of ibuprofen, insights from the mice model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Anti-Inflammatory Agents, Non-Steroidal; Basal Ganglia; Cytoprotection; Di | 2013 |
Antidepressant and antioxidative effect of Ibuprofen in the rotenone model of Parkinson's disease.
Topics: Animals; Antidepressive Agents; Antioxidants; Brain; Catalase; Depression; Dose-Response Relationshi | 2014 |
Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dyskinesia, Drug-Induced; Female; Ibuprofen; Levod | 2016 |
Ibuprofen and the mouse model of Parkinson's disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Disease Models, Animal; Ibuprofen; Mice; Ne | 2006 |